Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 18781891)

1.

Tumor stroma as a target in cancer.

Ahmed F, Steele JC, Herbert JM, Steven NM, Bicknell R.

Curr Cancer Drug Targets. 2008 Sep;8(6):447-53. Review.

PMID:
18781891
2.

Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery.

Bouzin C, Feron O.

Drug Resist Updat. 2007 Jun;10(3):109-20. Epub 2007 Apr 23. Review.

PMID:
17452119
3.

Clinical use of therapies targeting tumor vasculature and stroma.

Davis ID, Desai J.

Curr Cancer Drug Targets. 2008 Sep;8(6):498-508. Review.

PMID:
18781896
4.

Tumor microenvironment: the role of the tumor stroma in cancer.

Li H, Fan X, Houghton J.

J Cell Biochem. 2007 Jul 1;101(4):805-15. Review.

PMID:
17226777
5.

Immunotherapy: target the stroma to hit the tumor.

Kammertoens T, Schüler T, Blankenstein T.

Trends Mol Med. 2005 May;11(5):225-31. Review.

PMID:
15882610
6.

Tumor stroma.

Seljelid R, Jozefowski S, Sveinbjörnsson B.

Anticancer Res. 1999 Nov-Dec;19(6A):4809-22. Review.

PMID:
10697594
7.

Tumor stroma-associated antigens for anti-cancer immunotherapy.

Hofmeister V, Vetter C, Schrama D, Bröcker EB, Becker JC.

Cancer Immunol Immunother. 2006 May;55(5):481-94. Epub 2005 Oct 12. Review.

PMID:
16220326
8.

Hallmarks of cancer: interactions with the tumor stroma.

Pietras K, Ostman A.

Exp Cell Res. 2010 May 1;316(8):1324-31. doi: 10.1016/j.yexcr.2010.02.045. Epub 2010 Mar 6. Review.

PMID:
20211171
9.

[Tumor-stroma interactions].

Billottet C, Jouanneau J.

Bull Cancer. 2008 Jan;95(1):51-6. doi: 10.1684/bdc.2008.0560. Review. French.

PMID:
18230570
10.

The tumour microenvironment: a novel target for cancer therapy.

Hanna E, Quick J, Libutti SK.

Oral Dis. 2009 Jan;15(1):8-17. doi: 10.1111/j.1601-0825.2008.01471.x. Epub 2008 Nov 1. Review.

PMID:
18992016
11.

Targeting the tumor stroma in cancer therapy.

Anton K, Glod J.

Curr Pharm Biotechnol. 2009 Feb;10(2):185-91. Review.

PMID:
19199950
12.

Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers.

Bagley RG, Weber W, Rouleau C, Yao M, Honma N, Kataoka S, Ishida I, Roberts BL, Teicher BA.

Int J Oncol. 2009 Mar;34(3):619-27.

PMID:
19212666
13.

Vascular targeting: recent advances and therapeutic perspectives.

Hajitou A, Pasqualini R, Arap W.

Trends Cardiovasc Med. 2006 Apr;16(3):80-8. Review.

PMID:
16546688
14.

Prostatic tumor stroma: a key player in cancer progression.

Taylor RA, Risbridger GP.

Curr Cancer Drug Targets. 2008 Sep;8(6):490-7. Review.

PMID:
18781895
15.

Anti-cancer therapies targeting the tumor stroma.

Hofmeister V, Schrama D, Becker JC.

Cancer Immunol Immunother. 2008 Jan;57(1):1-17. Epub 2007 Jul 27. Review.

PMID:
17661033
16.

Anticancer therapeutics: a surge of new developments increasingly target tumor and stroma.

Broxterman HJ, Georgopapadakou NH.

Drug Resist Updat. 2007 Aug-Oct;10(4-5):182-93. Epub 2007 Sep 12.

PMID:
17855157
17.

Regulation of tumor-stromal fibroblast interactions: implications in anticancer therapy.

Kiaris H, Trimis G, Papavassiliou AG.

Curr Med Chem. 2008;15(29):3062-7. Review.

PMID:
19075653
18.

Targeting the stroma by T cells to limit tumor growth.

Zhang B.

Cancer Res. 2008 Dec 1;68(23):9570-3. doi: 10.1158/0008-5472.CAN-08-2414. Review.

19.

From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy.

Stacker SA, Achen MG.

Lymphat Res Biol. 2008;6(3-4):165-72. doi: 10.1089/lrb.2008.1015. Review.

PMID:
19093789
20.

Tumor-stroma interactions in tumorigenesis: lessons from stem cell biology.

Briest F, Berndt A, Clement J, Junker K, Eggeling Fv, Grimm S, Friedrich K.

Front Biosci (Elite Ed). 2012 Jan 1;4:1871-87. Review.

PMID:
22202004
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk